Sihe Wang, PhD is Section Head and Medical Director of Clinical Biochemistry and Director of Clinical Biochemistry Fellowship Training Program at Cleveland Clinic. He chairs clinical chemistry integration team for the Cleveland Clinic Health System which includes one Florida hospital, eight community hospitals and eighteen family health centers in Northeast Ohio. Additionally, he is a Clinical Chemistry Professor, Cleveland State University. His expertise includes general clinical chemistry and clinical application of mass spectrometry. Sihe is a diplomate of the American Board of Clinical Chemistry since 2005 and a fellow of the National Academy of Clinical Biochemistry since 2006.

Chromatography and mass spectrometry for specialty testing, general clinical chemistry, new biomarkers for cardiovascular or kidney diseases

Zhenhua GONG has completed his PhD at the age of 40 years from FUDAN University ,Shanghai China. He is pediatric surgeon, associated professor and director of a research team focusing on metabolic diseases and biliary atresia. He has published more than 10 papers in reputed journals and serving as an editorial board member of repute

metabolic diseases and biliary atresia.

Marek M Kowalczuk received his PhD degree in 1984 from the Faculty of Chemistry, Silesian University of Technology, and DSc degree in 1994 at the same University. He was a Visiting Lecturer at the University of Massachusetts in Amherst, MA, USA. in 1990 and Marie Curie EU fellow at the University of Bologna, Italy. Currently, he is Professor at the University of Wolverhampton, UK and at the Centre of Polymer and Carbon Materials, Polish Academy of Sciences, Zabrze, Poland. He is the author and co-author of over 120 scientific papers and a score of patents. His research interests are novel mass spectrometry techniques for analysis of polymers at the molecular level, mechanisms of anionic polymerization related to the synthesis of biodegradable polymers possessing desired architecture, forensic engineering of biodegradable and functional polymers.

Novel mass spectrometry techniques for analysis of polymers at the molecular level, mechanisms of anionic polymerization related to the synthesis of biodegradable polymers possessing desired architecture, forensic engineering of biodegradable and functional polymers.

Shawn R Campagna received his PhD from Princeton in 2006, after working with Prof. Martin Semmelhack on a joint project with Profs. Bonnie Bassler and Frederick Hughson to characterize the chemical properties of an interspecies bacterial signaling molecule, autoinducer-2. He then performed Post-doctoral research with Prof. Joshua Rabinowitz at the Lewis-Sigler Institute for Integrative Genomics at Princeton University where he developed mass spectrometric methods for the identification of novel biochemical pathways and natural products from whole cell extracts. He joined the Chemistry Department at UT Knoxville in 2007 where he has worked to develop new metabolomic and lipidomic techniques. He is currently an Associate Professor and Head of the UTK Biological and Small Molecule Mass Spectrometry Core.

Chromatography and mass spectrometry for specialty testing, general clinical chemistry, new biomarkers for cardiovascular or kidney diseases

Prof. Rogatsky serves as the Editor-in-Chief for the Journal of Chromatography and Separation Techniques (OMICS publishing group). During the last 10 years (from 2005) he has published over 30 scientific papers in per-reviewed journals (mostly as the first author) and has presented over 50 posters and lectures. Overall, he has made more than a hundred scientific presentations and publications. Eduard completed his M.Sc. in physical chemistry at Belarus State University (former USSR) in 1990. He completed his PhD in bioanalytical chemistry (Bar-Ilan University, Israel) in 1998. At the end of 1999, he started his post-doctorate at Albert Einstein College of Medicine and became a faculty member since 2001 and was a mass spectrometry director at the Biomarker Analytical Resource Core. From October 2015 Dr. Rogatsky is a supervisor of the Chemical Threat Laboratory in the Division of Environmental Health Sciences at Wadsworth Center, Albany NY, USA and continue to be an Adjunct Professor at Albert Einstein College of Medicine.

Design and development of ultra sensitive LC/MS, analytical assay of clinical biomarker and metabolomics, analysis of peptide hormone and protein, design and development of multi-dimentional chromatography platform.

Hui Xu has completed her PhD at the age of 34 years from Eberhard Karls University of Tuebeingen, Germany. She is a senior research fellow of Guangzhou University of Chinese Medicine and the vice director of Research Center of Chinese Herbal Resource Science and Engineering. She has published more than 10 papers in reputed journals.

Mass Spectrometry, Metabolemics, Proteomics

Dr. Simone König completed her PhD in Physical Chemistry at the University of Leipzig and time-out for motherhood, Simone König has done postdoctoral studies with one of the pioneers in biomedical mass spectrometry, Henry M. Fales, at the National Institutes of Health in Bethesda, MD. For over a decade, she heads the Proteomic Facility of the Interdisciplinary Center for Clinical Research at the Medical Faculty of the University of Münster, Germany. She has published more than 100 peer-reviewed papers and written and edited books. She serves as a reviewer for national and international funding organisations as well as journals and she organizes the Annual Münster Conference on Biomolecule Analysis.

biomedical mass spectrometry

Chrys Wesdemiotis received his Ph.D. degree with Helmut Schwarz at Technische Universität Berlin in 1979. He was a postdoctoral fellow with Fred W. McLafferty at Cornell University in 1980. After completing his military service in Greece (1981-3), he returned to Cornell as a senior research associate (1983-9). In 1989, he joined the faculty of the University of Akron, where he currently is Distinguished Professor of Chemistry, Polymers Science, and Integrated Bioscience. Research in the Wesdemiotis group focuses on the development and applications of multi-dimensional mass spectrometry methods for the characterization of new synthetic polymers and polymer-biomolecule conjugates and interfaces. Wesdemiotis served as a Member-at-Large for Education in the Board of Directors of the American Society for Mass Spectrometry (ASMS) and is a Fellow of the American Association for the Advancement of Science (AAAS). He is an Editor of the European Journal of Mass Spectrometry and a member of the Editorial Boards of the Journal of the American Society for Mass Spectrometry, International Journal of Mass Spectrometry, and Mass Spectrometry Reviews.

Mass spectrometry and tandem mass spectrometry: fundamental studies and analytical applications to macromolecules.

Dr. Brigitte Simons is a market development specialist at SCIEX, specializing in metabolomics using accurate mass time-of-flight mass spectrometry solutions. Prior to working at SCIEX, Brigitte received her Ph.D. in Chemical Biology at the University of Ottawa. She then completed two research post-doctoral fellowships at the Centre for Biologics Research at Health Canada and the National Institute of Heart Lung and Blood in Bethesda MD. Brigitte also spearheads an academic partnerships program for our North American business – which listeners can browse sciex.com for more information or contact Brigitte for more information.

ecializing in metabolomics using accurate mass time-of-flight mass spectrometry solutions.

Dr. Hui-Fen Wu currently is a distinguished professor in National Sun-Yat Sen University. She obtained PhD from University of Texas at Austin, USA (1994). She was a faculty in Tamkang University for 10 years. In 2006, she joined National Sun Yat-Sen University. Her research work is focused on applications of various nanomaterials for pathogenic bacteria analysis and cancer study. She has been served as editorial board members for 15 journals. To date, she has published 205 scientific journals, 250 conference presentation , 13 book chapters and 7 patents.

nanotechnology, microbiology and mass spectrometric techniques for biomedicine

Zhang QI is a major player of the research team in university project, she has been responsible for coordinating with members at the center of structure biology at Indiana University and Tulane University on solving the crystal structure of the MDM2/ribosomal protein complex. She has been developing an elegant and sophisticated multigene expression system to co-express and co-purify the novel protein complex in order to explore the structures and functions of the p53 regulators MDM2 and the ribosomal proteins. She has obtained extensive experience in the screening for therapeutic candidates and the biochemical characterization of drug targets as a postdoctoral researcher at Indiana University School of Medicine. Dr Zhang collaborated efficiently with scientists from various areas, such as molecular biology, cellular biology, biochemistry, computer-aided drug design, combinatorial chemistry, clinical pharmacology, drug analysis and high-throughput screening, facilitating the progression of drug discovery projects. Her research will be complementary to the mission of Tulane School of Medicine and Tulane Cancer Center in discovering cures for cancer diseases and building the essential bridge between basic research and clinical research to accomplish this objective.

Targeting the p53-pathway for the treatment of cancer; Study of p53 regulators by a combination of biochemical and structural analyses.

Bernhard Welz has completed his PhD at the age of 29 years from University of Stuttgart (Germany). He worked for Perkin-Elmer for 32 years, the last 16 as Director of Applied Research. After his retirement, he went to Brazil and worked as visiting professor at several Universities. Now he is voluntary professor at the Federal University of Santa Catarina. He has published more than 280 papers in reputed journals with more than 9600 citations; he has an H-index of 54.

Mass Spectrometry

Zikri Arslan received his PhD in 2000 from the University of Massachusetts at Amherst in analytical chemistry with an emphasis on applied plasma source mass spectrometry. He was a National Research Council (NRC) post-doctoral scholar between 2000 and 2002; worked at NOAA/NEFSC Howard Marine Sciences Laboratory in Sandy Hook, NJ. He also worked as research scientist (2002-2003) at the University of Maryland, Chesapeake Biological Laboratory on otolith micromilling protocols for identification of bluefin tuna stocks. His research interests span from nanoparticle detection to analytical method development involving plasma spectrometry. He published more than 50 papers, served as guest editor and reviewer for major analytical and environmental chemistry journals.

plasma spectrometry